| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Health Sciences | 141 | 3.4K | 367K |
2 | Engineering | 108 | 3.1K | 210.7K |
3 | Education | 49 | 353 | 64.8K |
4 | Business | 27 | 77 | 4.1K |
5 | Arts | 12 | 17 | 899 |
Eli Lilly (United States)
×
30.7K
Publications
4.8M
Citations
| Year | Citations | |
|---|---|---|
2011 | 18.4K | |
2014 | 8K | |
2011 | 7K | |
2007 | 6.7K | |
1996 | 6.3K | |
2001 | 6.1K | |
1994 | 6.1K | |
2001 | 4.5K | |
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial John Dormandy, B Charbonnel, D.J.A. Eckland, Diabetes ManagementCardiovascular DiseaseHealth PolicyDiabetesSecondary Prevention | 2005 | 4.1K |
2000 | 3.9K |
Page 1
Page 1